Showing results (971-980 of 1,045) with videos related to

Sort By:
Pageof 105
Nature Genetics|December 26, 2001
Positional cloning of the combined hyperlipidemia gene Hyplip1Jackie S Bodnar, Aurobindo Chatterjee, Lawrence W Castellani, et al.
Research Square|January 30, 2023
A spatial map of human macrophage niches reveals context-dependent macrophage functions in colon and breast cancerMagdalena Matusiak, John W Hickey, Bogdan Luca, et al.
Molecular Neurodegeneration|January 11, 2022
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brainEnquan Xu, Ravindra Boddu, Hisham A Abdelmotilib, et al.
JCI Insight|May 17, 2019
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesisLance W Middleton, Zhewei Shen, Sushama Varma, et al.
International Journal of Cancer|June 8, 2001
Family history of cancer and risk of esophageal and gastric cancers in the United StatesP K Dhillon, D C Farrow, T L Vaughan, et al.
Science Advances|April 8, 2022
The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signalingJoshua K Tay, Chunfang Zhu, June Ho Shin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, P D Hansten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Clinically Relevant Molecular Subtypes in LeiomyosarcomaXiangqian Guo, Vickie Y Jo, Anne M Mills, et al.
Genomics|May 26, 2001
Genome-tagged mice (GTM): two sets of genome-wide congenic strainsO A Iakoubova, C L Olsson, K M Dains, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 30, 1998
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal refluxT L Vaughan, D C Farrow, P D Hansten, et al.
Pageof 105